Depreciation, Depletion and Amortization in USD of Tvardi Therapeutics, Inc. from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and change rate from 2012 to Q1 2025.
  • Tvardi Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $0.000, a 100% decline year-over-year.
  • Tvardi Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $192,000.000, a 25.9% decline from 2023.
  • Tvardi Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $259,000.000, a 4.44% increase from 2022.
  • Tvardi Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $248,000.000, unchanged from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 -$42,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q1 2024 $42,000 -$16,000 -27.6% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q1 2023 $58,000 -$5,000 -7.9% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q1 2022 $63,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 $63,000 +$15,000 +31.2% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q1 2020 $48,000 -$2,000 -4% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q1 2019 $50,000 -$75,000 -60% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 $125,000 +$3,000 +2.5% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q1 2017 $122,000 -$608,000 -83.3% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q1 2016 $730,000 +$537,000 +2.8% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017
Q1 2015 $193,000 -$4,000 -2% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q1 2014 $197,000 -$1,000 -0.5% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015
Q1 2013 $198,000 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014

Tvardi Therapeutics, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $192,000 -$67,000 -25.9% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 $259,000 +$11,000 +4.4% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 $248,000 $0 0% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025
2021 $248,000 +$39,000 +18.7% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024
2020 $209,000 +$11,000 +5.6% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023
2019 $198,000 -$172,000 -46.5% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 $370,000 -$125,000 -25.3% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $495,000 -$970,000 -66.2% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 $1,465,000 +$626,000 +74.6% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2015 $839,000 +$56,000 +7.2% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018
2014 $783,000 -$6,000 -0.76% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 $789,000 -$232,000 -22.7% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 $1,021,000 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.